Clinical Trial Update: Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation [Phase 4]

View source ↗

Summary

Phase 4 exploratory trial assessing omega-3-acid ethyl esters (TAK-085) on vascular endothelial function in hyperlipidemia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• TAK-085 (omega-3-acid ethyl esters) (omega-3-acid ethyl esters)

Snippet

Sponsor: Takeda | Conditions: Hyperlipidemia | Phase 4 | Status: COMPLETED | Results posted: 2019-05-06